Immune checkpoint blockade (ICB) of the PD-1/PD-L1 (programmed death protein 1/programmed death-ligand 1) signaling pathway, have fundamentally changed the treatment of advanced urothelial carcinoma (UC). Here, CD274 is linked to urothelial carcinoma.